A Study of HDM1002 Tablets on Cardiac Repolarization in Healthy Subjects

Clinical trial NCT07594847 · RECRUITING

Trial details

NCT number: NCT07594847
Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Subject

Start date: 2026-03-07
Primary completion: 2026-09-25
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.